Tech Company Financing Transactions

LogicBio Therapeutics Funding Round

LogicBio Therapeutics secured a $45 million Series B funding round on 6/29/2017. Investors included Arix Bioscience, Edmond de Rothschild Investment Partners and OrbiMed.

Transaction Overview

Announced On
6/29/2017
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series B
Proceeds Purpose
Proceeds of the Series B financing will be used to complete pre-clinical development and advance the company's lead programmes into clinical studies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
815 Perseus Dr.
Foster City, CA 94404
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
LogicBio Therapeutics is a gene therapy start-up developing viral vectors for the treatment of genetic diseases.
Profile
LogicBio Therapeutics LinkedIn Company Profile
Social Media
LogicBio Therapeutics Company Twitter Account
Company News
LogicBio Therapeutics News
Facebook
LogicBio Therapeutics on Facebook
YouTube
LogicBio Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Leszek Lisowski
  Leszek Lisowski LinkedIn Profile  Leszek Lisowski Twitter Account  Leszek Lisowski News  Leszek Lisowski on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/29/2017: Swift Navigation venture capital transaction
Next: 6/29/2017: PatientPoint venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on tech company VC transactions. VC investment data records reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary